Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094612 · ClinicalTrials.gov registry record · NA
Effectiveness of the Quotient® ADHD Assessment in a System of Care
A NA study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- NA
- Development phase
- 207
- Enrollment target
NCT02094612 is a NA study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 207 participants.
The verdict
NCT02094612, a NA study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
Study Summary
The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.
Interventions
- DEVICE Quotient®
- BEHAVIORAL Usual Clinic ADHD Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02094612
The ClinicalTrials.gov registry entry for NCT02094612 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quotient® is the first listed.
NCT02094612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02094612 about?
NCT02094612 is a clinical study titled "Effectiveness of the Quotient® ADHD Assessment in a System of Care". The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.
What is the current status of trial NCT02094612?
This trial is currently terminated. It is a NA study. The enrollment target is 207 participants. The study started on 2014-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02094612?
The interventions under investigation include: Quotient® (DEVICE), Usual Clinic ADHD Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT02094612?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.